...Formula Pharmaceuticals Inc. has licensed a chimeric antigen receptor (CAR) technology from Fondazione Matilde Tettamanti Menotti De Marchi Onlus that it thinks...

...testing in 2016. Formula declined to provide financial terms, and Fondazione Tettamanti could not be reached. Fondazione Matilde Tettamanti Menotti De Marchi Onlus...